Skip to content

GDM Screening During COVID Pandemic. IADPSG vs WHO '99 Criteria

Screening of GDM During COVID Pandemic in an Italian Setting. Comparison Between IADPSG and WHO '99 Criteria

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05026840
Enrollment
120
Registered
2021-08-30
Start date
2020-03-01
Completion date
2021-09-30
Last updated
2022-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison Between IADPSG vs WHO '99 Criteria, GDM Screening During COVID Pandemic

Brief summary

All pregnant women who performed an OGTT following Italian Guidelines and then delivered at our University Hospital from march 2020 to march 2021 were prospectively enrolled in this study. Primary outcome of the study was the number of women to whom was diagnosed GDM with only the fasting glucose value (≥ 92 mg/dl), following Italian Diabetes Societies recommendations for COVID 19 pandemic period. In the same time, we prospectively collected the data of women who became diabetic following the criteria of WHO 1999 (fast glucose value ≥ 120 mg/dl, 2 hours later ≥ 140 mg/dl) still in use in some large countries like India. From the clinical charts, we reported the distribution of risk factors for GDM (maternal age ≥ 35 years, family history for diabetes type 2, ethnia, BMI ≥ 25, previous GDM) and clinical outcomes such as hypertensive disorders, preterm birth, macrosomia, intrauterine growth restriction and Caesarean section in emergency. These data will be compared between the 2 groups consisting in those diagnosed with only IADPSG criteria versus those diagnosed with only WHO '99 criteria.

Interventions

PROCEDUREGDM screening criteria

difference in risk factors and clinical outcomes between groups

Sponsors

University of Messina
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Pregnant women who perform GDM screening -

Exclusion criteria

Twin pregnancies \-

Design outcomes

Primary

MeasureTime frameDescription
prevalence of women with a diagnosis of GDM following guidelines during COVID pamdemicfrom march 2020 to march 2021evaluation of fast glucose level in the period recommended for GDM screening following Italian guidelines

Secondary

MeasureTime frameDescription
GDM diagnosis with IADPSG criteria versus WHO '99 criteriafrom March 2020 to March 2021difference in risk factors and clinical outcomes between groups

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026